Hyperglycemia exacerbates burn-induced liver inflammation via noncanonical nuclear factor-κb pathway activation

Molecular Medicine

Volumn 18, Issue 6, 2012, Pages 948-956

  Kulp, Gabriela A ^a,b   Tilton, Ronald G ^a,b   Herndon, David N ^a   Jeschke, Marc G ^c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c Sunnybrook Health Sciences Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; DNA; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BURN; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HEPATITIS; HYPERGLYCEMIA; INSULIN RELEASE; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; BURNS; CYTOKINES; CYTOSOL; DNA; HYPERGLYCEMIA; INFLAMMATION; INSULIN; LIVER; MALE; NF-KAPPA B; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84865233923     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00357     Document Type: Article

References (44)

1. van den Berghe G, et al. (2001) Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 345:1359-67.
2. van den Berghe G. (2003) Insulin therapy for the critically ill patient. Clin. Cornerstone. 5:56-63.
3. van den Berghe G, Mesotten D, Vanhorebeek I. (2009) Intensive insulin therapy in the intensive care unit. CMAJ. 180:799-800.
4. Jeschke MG, Klein D, Herndon DN. (2004) Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann. Surg. 239:553-60.
5. Jeschke MG, et al. (2010) Intensive insulin ther-apy in severely burned pediatric patients: a prospective randomized trial. Am. J. Respir. Crit. Care Med. 182:351-9.
6. Hemmila MR, Taddonio MA, Arbabi S, Maggio PM, Wahl WL. (2008) Intensive insulin therapy is associated with reduced infectious complications in burn patients. Surgery. 144:629-37.
7. Verhofstad MH, Hendriks T. (1996) Complete prevention of impaired anastomotic healing in diabetic rats requires preoperative blood glucose control. Br. J. Surg. 83:1717-21.
8. Gore DC, et al. (2001) Association of hyperglycemia with increased mortality after severe burn injury. J. Trauma. 51:540-4.
9. Mowlavi A, Andrews K, Milner S, Herndon DN, Heggers JP. (2000) The effects of hyperglycemia on skin graft survival in the burn patient. Ann. Plast. Surg. 45:629-32.
10. Krzyzaniak M, et al. (2011) Burn-induced acute lung injury requires a functional Toll-like recep-tor 4. Shock. 36:24-9.
11. Heuer JG, et al. (2006) Effects of hyperglycemia and insulin therapy on outcome in a hyper-glycemic septic model of critical illness. J. Trauma. 60:865-72.
12. Vanhorebeek I, et al. (2009) Hyperglycemic kidney damage in an animal model of prolonged critical illness. Kidney Int. 76:512-20.
13. Zhang XJ, Meng C, Chinkes DL, Herndon DN. (2009) Beneficial effects of insulin on cell proliferation and protein metabolism in skin donor site wound. J. Surg. Res. 168:e155-61.
14. Chen XL, et al. (2005) p38 mitogen-activated pro-tein kinase inhibition attenuates burn-induced liver injury in rats. Burns. 31:320-30.
15. Jeschke MG, et al. (2001) Cell proliferation, apo-ptosis, NF-kappaB expression, enzyme, protein, and weight changes in livers of burned rats. Am. J. Physiol. Gastrointest. Liver Physiol. 280:G1314-20.
16. Nishiura T, et al. (2000) Gene expression and cy-tokine and enzyme activation in the liver after a burn injury. J. Burn Care Rehabil. 21:135-41.
17. Jeschke MG. (2009) The hepatic response to ther-mal injury: is the liver important for postburn outcomes? Mol. Med. 15:337-51.
18. Gauglitz GG, et al. (2009) Post-burn hepatic in-sulin resistance is associated with endoplasmic reticulum (ER) stress. Shock. 33:299-305.
19. Al-Mousawi AM, et al. (2010) Impact of anesthe-sia, analgesia, and euthanasia technique on the inflammatory cytokine profile in a rodent model of severe burn injury. Shock. 34:261-8.
20. Starkey JM, et al. (2006) Diabetes-induced activation of canonical and noncanonical nuclear factor-κB pathways in renal cortex. Diabetes. 55:1252-1259.
21. Jeschke MG, et al. (2008) Pathophysiologic response to severe burn injury. Ann. Surg. 248:387-401.
22. Gauglitz GG, et al. (2008) Characterization of the inflammatory response during acute and postacute phases after severe burn. Shock. 30:503-7.
23. Zarnegar B, Yamazaki S, He JQ, Cheng G. (2008) Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc. Natl. Acad. Sci. U. S. A. 105:3503-8.
24. Madge LA, May MJ. (2010) Classical NF-kappaB activation negatively regulates non-canonical NF-kappaB-dependent CXCL12 expression. J. Biol. Chem. 285:38069-77.
25. Kulp GA, Herndon DN, Lee JO, Suman OE, Jeschke MG. (2010) Extent and magnitude of cat-echolamine surge in pediatric burned patients. Shock. 33:369-74.
26. Siebenlist U, Franzoso G, Brown K. (1994) Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10:405-55.
27. Baldwin AS Jr. (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-83.
28. Rothwarf DM, Zandi E, Natoli G, Karin M. (1998) IKK-gamma is an essential regulatory sub-unit of the IkappaB kinase complex. Nature. 395:297-300.
29. Barnes PJ. (1997) Nuclear factor-kappa B. Int. J. Biochem. Cell Biol. 29:867-70.
30. Hayden MS, Ghosh S. (2004) Signaling to NF-kappaB. Genes. Dev. 18:2195-224.
31. Karin M, Ben-Neriah Y. (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:621-63.
32. Pahl HL. (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 18:6853-66.
33. Bonizzi G, et al. (2004) Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J. 23:4202-10.
34. Bonizzi G, Karin M. (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280-8.
35. Senftleben U, et al. (2001) Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science. 293:1495-9.
36. Ghosh S, Baltimore D. (1990) Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature. 344:678-82.
37. Dejardin E, et al. (2002) The lymphotoxin-beta re-ceptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity. 17:525-35.
38. Xiao G, Harhaj EW, Sun SC. (2001) NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell. 7:401-9.
39. Coope HJ, et al. (2002) CD40 regulates the pro-cessing of NF-kappaB2 p100 to p52. EMBO J. 21:5375-85.
40. Xiao G, et al. (2001) Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J. 20:6805-15.
41. Claudio E, Brown K, Park S, Wang H, Siebenlist U. (2002) BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3:958-65.
42. Kayagaki N, et al. (2002) BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity. 17:515-24.
43. Jeschke MG, Boehning DF, Finnerty CC, Hern-don DN. (2007) Effect of insulin on the inflammatory and acute phase response after burn injury. Crit. Care Med. 35:S519-23.
44. Demling RH. (2000) Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat. Wound Repair Regen. 8:97-102.